Ozempic's Hidden Liver Impact and Gallbladder Risks

Summary

While Ozempic is known for weight loss, new research suggests it directly impacts the liver in ways not widely discussed. A study from the University of Toronto found Ozempic can heal liver inflammation and scarring, even without significant weight loss. This was demonstrated in mice engineered to not lose weight on the drug, showing direct GLP-1 receptor action in the liver. However, this benefit is primarily studied in patients with specific, doctor-supervised liver conditions, not the general population using Ozempic for weight loss. In contrast, a case study revealed a 67-year-old woman experienced severe liver damage, with enzyme levels over 1,600, just two weeks into taking Ozempic for weight loss, highlighting a potential risk of acute liver injury, especially in women. Furthermore, Ozempic can negatively affect the gallbladder, leading to stagnant bile, sludge, and gallstones, a risk now noted on its warning label. The drug's long-lasting stimulation of GLP-1 receptors, compared to the body's natural hormone, may overwhelm these systems. The transcript also points out that many seeking Ozempic are addressing underlying insulin resistance, a root cause of weight gain. When stopping Ozempic, a significant portion of weight is regained, and muscle loss, not just fat, is a concern. Recommendations for those on Ozempic include sufficient protein, fermented fiber, resistance exercise, and lowering carbohydrates to combat insulin resistance, which is reversible, unlike advanced liver scarring.